Canada Life’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,962
Closed -$12K 2553
2021
Q3
$12K Hold
1,962
﹤0.01% 2498
2021
Q2
$17K Hold
1,962
﹤0.01% 2510
2021
Q1
$30K Hold
1,962
﹤0.01% 2446
2020
Q4
$32K Hold
1,962
﹤0.01% 2436
2020
Q3
$27K Hold
1,962
﹤0.01% 2367
2020
Q2
$41K Buy
+1,962
New +$34.7K ﹤0.01% 2288

Other funds holding BCEL

Canada Life's BCEL Position: Q4 2021 in Review

Canada Life sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q4 2021, closing a stake of 1,962 shares — an estimated $12K sold.

Canada Life first reported a position in BCEL in Q2 2020 and held it in 6 quarters. The position peaked at $41K in Q2 2020. 100 funds tracked by Wall St. Rank hold BCEL as of Q4 2021.

  • Canada Life reported no remaining Atreca, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • Canada Life sold 1,962 Atreca, Inc. Class A Common Stock shares in Q4 2021, an estimated $12K.
  • Canada Life first reported a position in Atreca, Inc. Class A Common Stock in Q2 2020 and held it in 6 quarters.
  • Canada Life's Atreca, Inc. Class A Common Stock position peaked at $41K in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.